Vivani Medical (NASDAQ:VANI – Get Free Report) is projected to post its quarterly earnings results before the market opens on Tuesday, March 25th. Analysts expect Vivani Medical to post earnings of ($0.10) per share for the quarter.
Vivani Medical Price Performance
VANI stock opened at $1.09 on Monday. The company has a fifty day moving average price of $1.14 and a two-hundred day moving average price of $1.21. The stock has a market cap of $64.57 million, a price-to-earnings ratio of -2.42 and a beta of 3.20. Vivani Medical has a one year low of $1.03 and a one year high of $2.22.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright reissued a “buy” rating and issued a $4.00 target price on shares of Vivani Medical in a research report on Thursday, March 13th.
Vivani Medical Company Profile
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
See Also
- Five stocks we like better than Vivani Medical
- Trading Stocks: RSI and Why it’s Useful
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- Industrial Products Stocks Investing
- 3 ETFs to Ride the VIX Surge During Market Volatility
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
